NPRL2 and neoplasm: In addition primary tumor growth was significantly suppressed and tumor progression and metastasis were inhibited following either intratumoral injection or systemic administration of a protamine-complexed recombinant adenoviral vector of NPRL2 in various human lung cancer mouse models (16).